Published in Front Pharmacol on June 10, 2014
Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives. Antioxidants (Basel) (2015) 0.85
Higher Serum Uric Acid Is Associated with Higher Bone Mineral Density in Chinese Men with Type 2 Diabetes Mellitus. Int J Endocrinol (2016) 0.84
The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease. Sultan Qaboos Univ Med J (2015) 0.84
Effects of Curculigoside on Memory Impairment and Bone Loss via Anti-Oxidative Character in APP/PS1 Mutated Transgenic Mice. PLoS One (2015) 0.78
Hormesis: Decoding Two Sides of the Same Coin. Pharmaceuticals (Basel) (2015) 0.77
Sex hormonal regulation and hormesis in aging and longevity: role of vitagenes. J Cell Commun Signal (2014) 0.76
Preclinical and clinical issues in Alzheimer's disease drug research and development. Front Pharmacol (2014) 0.75
A reduction of viral mRNA, proteins and induction of altered morphogenesis reveals the anti-HTLV-1 activity of the labdane-diterpene myriadenolide in vitro. BMC Microbiol (2014) 0.75
Antioxidant Effect of Fructus Ligustri Lucidi Aqueous Extract in Ovariectomized Rats Is Mediated through Nox4-ROS-NF-κB Pathway. Front Pharmacol (2017) 0.75
Beneficial Effects and Toxicity Studies of Xian-ling-gu-bao on Bone Metabolism in Ovariectomized Rats. Front Pharmacol (2017) 0.75
Osteoporosis: now and the future. Lancet (2011) 5.81
Mitochondria and cancer. Nat Rev Cancer (2012) 4.81
Mitochondrial DNA mutations in disease and aging. Environ Mol Mutagen (2010) 3.10
Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci (2007) 2.77
The frequency of U-shaped dose responses in the toxicological literature. Toxicol Sci (2001) 2.65
The noncanonical NF-κB pathway. Immunol Rev (2012) 2.57
The hormetic dose-response model is more common than the threshold model in toxicology. Toxicol Sci (2003) 2.35
Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses. Nat Neurosci (2009) 2.31
The occurrence of hormetic dose responses in the toxicological literature, the hormesis database: an overview. Toxicol Appl Pharmacol (2005) 2.29
Hormesis outperforms threshold model in National Cancer Institute antitumor drug screening database. Toxicol Sci (2006) 2.25
Chaperone machines for protein folding, unfolding and disaggregation. Nat Rev Mol Cell Biol (2013) 2.24
Hormesis: why it is important to toxicology and toxicologists. Environ Toxicol Chem (2008) 2.09
How many transcription factors does it take to turn on the heme oxygenase-1 gene? Am J Respir Cell Mol Biol (2006) 1.94
Hormesis and medicine. Br J Clin Pharmacol (2008) 1.91
Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. J Pharmacol Exp Ther (2008) 1.86
Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid Redox Signal (2010) 1.77
Hormesis and plant biology. Environ Pollut (2008) 1.72
Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders. Front Biosci (2007) 1.65
Mitochondria as chi. Genetics (2008) 1.53
Hormetic mechanisms. Crit Rev Toxicol (2013) 1.52
Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit, which are ameliorated by N-acetyl-L-cysteine. J Bone Miner Res (2013) 1.52
Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease. Alzheimers Dement (2009) 1.49
Hormesis is central to toxicology, pharmacology and risk assessment. Hum Exp Toxicol (2010) 1.46
Historical blunders: how toxicology got the dose-response relationship half right. Cell Mol Biol (Noisy-le-grand) (2005) 1.45
Chemical hormesis: its historical foundations as a biological hypothesis. Hum Exp Toxicol (2000) 1.40
Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity. Biochim Biophys Acta (2011) 1.40
Radiation hormesis: its historical foundations as a biological hypothesis. Hum Exp Toxicol (2000) 1.40
Nitric oxide in cell survival: a janus molecule. Antioxid Redox Signal (2009) 1.37
Hormesis predicts low-dose responses better than threshold models. Int J Toxicol (2008) 1.33
The hormesis database: the occurrence of hormetic dose responses in the toxicological literature. Regul Toxicol Pharmacol (2011) 1.31
Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity. Mol Aspects Med (2011) 1.27
Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochem Res (2008) 1.26
TNAP, TrAP, ecto-purinergic signaling, and bone remodeling. J Cell Biochem (2008) 1.24
Nitrosative stress, cellular stress response, and thiol homeostasis in patients with Alzheimer's disease. Antioxid Redox Signal (2006) 1.20
Bioenergetics in human evolution and disease: implications for the origins of biological complexity and the missing genetic variation of common diseases. Philos Trans R Soc Lond B Biol Sci (2013) 1.19
Radiation hormesis: the demise of a legitimate hypothesis. Hum Exp Toxicol (2000) 1.18
Role of nuclear factor κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents. Exp Biol Med (Maywood) (2011) 1.18
Redox homeostasis and cellular stress response in aging and neurodegeneration. Methods Mol Biol (2010) 1.18
Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies. Biochim Biophys Acta (2013) 1.09
The pivotal role of the alternative NF-kappaB pathway in maintenance of basal bone homeostasis and osteoclastogenesis. J Bone Miner Res (2010) 1.09
Curcumin activates defensive genes and protects neurons against oxidative stress. Antioxid Redox Signal (2006) 1.08
Hormesis: its impact on medicine and health. Hum Exp Toxicol (2012) 1.08
Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes. Neurochem Res (2006) 1.07
The marginalization of hormesis. Hum Exp Toxicol (2000) 1.07
Resveratrol commonly displays hormesis: occurrence and biomedical significance. Hum Exp Toxicol (2010) 1.07
Curcumin and the cellular stress response in free radical-related diseases. Mol Nutr Food Res (2008) 1.06
Parathyroid hormone and parathyroid hormone-related protein analogs as therapies for osteoporosis. Curr Osteoporos Rep (2013) 1.06
Tales of two similar hypotheses: the rise and fall of chemical and radiation hormesis. Hum Exp Toxicol (2000) 1.06
Clinical utility and analytical challenges in measurement of cerebrospinal fluid amyloid-β(1-42) and τ proteins as Alzheimer disease biomarkers. Clin Chem (2013) 1.04
Bilirubin: an endogenous scavenger of nitric oxide and reactive nitrogen species. Redox Rep (2006) 1.02
An assessment of anxiolytic drug screening tests: hormetic dose responses predominate. Crit Rev Toxicol (2008) 1.02
Hormesis provides a generalized quantitative estimate of biological plasticity. J Cell Commun Signal (2011) 1.02
Vitagenes, dietary antioxidants and neuroprotection in neurodegenerative diseases. Front Biosci (Landmark Ed) (2009) 1.02
HSF transcription factor family, heat shock response, and protein intrinsic disorder. Curr Protein Pept Sci (2012) 1.02
Oxidative stress, redox homeostasis and cellular stress response in Ménière's disease: role of vitagenes. Neurochem Res (2010) 1.00
Biphasic dose responses in biology, toxicology and medicine: accounting for their generalizability and quantitative features. Environ Pollut (2013) 1.00
The Keap1/Nrf2 protein axis plays a role in osteoclast differentiation by regulating intracellular reactive oxygen species signaling. J Biol Chem (2013) 1.00
A novel mouse HSF3 has the potential to activate nonclassical heat-shock genes during heat shock. Mol Biol Cell (2009) 0.99
Friedreich's ataxia: from disease mechanisms to therapeutic interventions. Antioxid Redox Signal (2006) 0.99
Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's disease. J Neurochem (2014) 0.98
Redox proteomics in aging rat brain: involvement of mitochondrial reduced glutathione status and mitochondrial protein oxidation in the aging process. J Neurosci Res (2010) 0.98
Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. J Neurosci Res (2006) 0.97
Natural antioxidants in Alzheimer's disease. Expert Opin Investig Drugs (2007) 0.97
HSF1-dependent upregulation of Hsp70 by sulfhydryl-reactive inducers of the KEAP1/NRF2/ARE pathway. Chem Biol (2011) 0.96
The role of inflammasome in Alzheimer's disease. Ageing Res Rev (2014) 0.95
Cellular stress responses, mitostress and carnitine insufficiencies as critical determinants in aging and neurodegenerative disorders: role of hormesis and vitagenes. Neurochem Res (2010) 0.95
The hormetic role of dietary antioxidants in free radical-related diseases. Curr Pharm Des (2010) 0.95
APPswe/Aβ regulation of osteoclast activation and RAGE expression in an age-dependent manner. J Bone Miner Res (2011) 0.94
Redox regulation of heat shock protein expression by signaling involving nitric oxide and carbon monoxide: relevance to brain aging, neurodegenerative disorders, and longevity. Antioxid Redox Signal (2006) 0.94
Heat shock transcription factor 1 localizes to sex chromatin during meiotic repression. J Biol Chem (2010) 0.93
Redox regulation of cellular stress response by ferulic acid ethyl ester in human dermal fibroblasts: role of vitagenes. Clin Dermatol (2008) 0.93
In vivo protective effects of ferulic acid ethyl ester against amyloid-beta peptide 1-42-induced oxidative stress. J Neurosci Res (2006) 0.92
Toxicology rewrites its history and rethinks its future: giving equal focus to both harmful and beneficial effects. Environ Toxicol Chem (2011) 0.92
Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's disease. PLoS One (2014) 0.92
Reduction of arthritic symptoms by low dose radiation therapy (LD-RT) is associated with an anti-inflammatory phenotype. Int J Radiat Biol (2012) 0.92
Dose response biology: the case of resveratrol. Hum Exp Toxicol (2010) 0.91
Oxidative modification of lipoic acid by HNE in Alzheimer disease brain. Redox Biol (2013) 0.91
Hormesis in high-throughput screening of antibacterial compounds in E coli. Hum Exp Toxicol (2010) 0.91
Stress proteins in aging and life span. Int J Hyperthermia (2013) 0.90
Bilirubin as an endogenous modulator of neurotrophin redox signaling. J Neurosci Res (2008) 0.90
Stress responses, vitagenes and hormesis as critical determinants in aging and longevity: Mitochondria as a "chi". Immun Ageing (2013) 0.89
Relationship between amyloid-beta and the ubiquitin-proteasome system in Alzheimer's disease. Neurol Res (2014) 0.89
Historical foundations of wound healing and its potential for acceleration: dose-response considerations. Wound Repair Regen (2013) 0.88
Hormesis: why it is important to biogerontologists. Biogerontology (2012) 0.88
Low dose radiation therapy (LD-RT) is effective in the treatment of arthritis: animal model findings. Int J Radiat Biol (2012) 0.88
Neuroprotective features of carnosine in oxidative driven diseases. Mol Aspects Med (2011) 0.88
Markers of cholesterol transport are associated with amyloid deposition in the brain. Neurobiol Aging (2013) 0.87
Administration of carnosine in the treatment of acute spinal cord injury. Biochem Pharmacol (2011) 0.87
Hormesis: Toxicological foundations and role in aging research. Exp Gerontol (2012) 0.86
Oxidative damage and amyloid-β metabolism in brain regions of the longest-lived rodents. J Neurosci Res (2013) 0.86
Senescence-accelerated OXYS rats: a model of age-related cognitive decline with relevance to abnormalities in Alzheimer disease. Cell Cycle (2014) 0.85
Modulation of the epileptic seizure threshold: implications of biphasic dose responses. Crit Rev Toxicol (2008) 0.85
Cellular stress response, sirtuins and UCP proteins in Alzheimer disease: role of vitagenes. Immun Ageing (2013) 0.85
Vitagenes, cellular stress response, and acetylcarnitine: relevance to hormesis. Biofactors (2009) 0.85
The role of homocysteine in bone remodeling. Clin Chem Lab Med (2013) 0.85
Alzheimer's disease drugs: an application of the hormetic dose-response model. Crit Rev Toxicol (2008) 0.84
Carnosinase levels in aging brain: redox state induction and cellular stress response. Antioxid Redox Signal (2009) 0.84
Amyloid beta peptide is elevated in osteoporotic bone tissues and enhances osteoclast function. Bone (2014) 0.83
Systemic oxidative stress and conversion to dementia of elderly patients with mild cognitive impairment. Biomed Res Int (2014) 0.83